Achilles Therapeutics plc (ACHL)
Mar 20, 2025 - ACHL was delisted pending liquidation
1.480
0.00 (0.00%)
Inactive · Last trade price on Mar 21, 2025
Achilles Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Achilles Therapeutics stock had an average target of $4.00, with a low estimate of $2.00 and a high estimate of $6.00.
Price Target: $4.00 (+170.27%)
Analyst Consensus: Buy
Price Target
Analyst Ratings
The average analyst rating for Achilles Therapeutics stock from 2 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.18
from -1.74
EPS Next Year
-0.12
from -0.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | n/a | n/a | ||
| Avg | n/a | n/a | ||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.19 | -0.13 | ||
| Avg | -0.18 | -0.12 | ||
| Low | -0.18 | -0.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |